Open AccessFDA approves Alzheimer's drug against the recommendation of its scientific panel. Be very concerned.
Author(s) -
Joshua R. Freeman
Publication year - 2021
Publication title -
rrnmf neuromuscular journal
Language(s) - English
Resource type - Journals
ISSN - 2692-3092
DOI - 10.17161/rrnmf.v2i5.15979
Subject(s) - drug , medicine , pharmacology